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Abstract In most vertebrates, the upper digestive tract is composed of muscularized jaws linked
to the esophagus that permits food ingestion and swallowing. Masticatory and esophagus striated
muscles (ESM) share a common cardiopharyngeal mesoderm (CPM) origin, however ESM are
unusual among striated muscles as they are established in the absence of a primary skeletal muscle
scaffold. Using mouse chimeras, we show that the transcription factors Tbx1 and Isl1 are required
cell-autonomously for myogenic specification of ESM progenitors. Further, genetic loss-of-function
and pharmacological studies point to MET/HGF signaling for antero-posterior migration of
esophagus muscle progenitors, where Hgf ligand is expressed in adjacent smooth muscle cells.
These observations highlight the functional relevance of a smooth and striated muscle progenitor
dialogue for ESM patterning. Our findings establish a Tbx1-Isl1-Met genetic hierarchy that uniquely
regulates esophagus myogenesis and identify distinct genetic signatures that can be used as
framework to interpret pathologies arising within CPM derivatives.
DOI: https://doi.org/10.7554/eLife.47460.001
Introduction
Evolution of vertebrates has been marked by the emergence of muscularized jaws that transitioned
them from filter feeders to active predators (Glenn Northcutt, 2005). Considerable diversity in
developmental origins and regulation of skeletal muscles point to important functional differences
that remain unexplored. Muscles of the trunk originate from the segmented somites, whereas head
muscles arise independently from the cardiopharyngeal mesoderm (CPM) located anterior to the
somites (Diogo et al., 2015; Sambasivan et al., 2011). The specification of head and trunk muscles
involves divergent genetic regulatory networks, to activate the bHLH myogenic regulatory factors
(MRFs) Myf5, Mrf4, Myod and Myogenin that play crucial roles in governing striated muscle cell fate
and differentiation (Comai et al., 2014; Kassar-Duchossoy et al., 2005; Rudnicki et al., 1993).
While somitic myogenic progenitors are regulated primarily by the Pax3/Pax7 paired/homeodo-
main genes and Myf5 that act genetically upstream of Myod (Kassar-Duchossoy et al., 2005;
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Relaix et al., 2005; Tajbakhsh et al., 1997), cardiopharyngeal mesoderm progenitors, that colonize
pharyngeal arches and form craniofacial and some neck muscles, are regulated by a Pax3-indepen-
dent regulatory network (Heude et al., 2018; Sambasivan et al., 2011). CPM progenitors specified
by Tbx1 and Isl1 genes are bipotent as they form branchiomeric subsets of head/neck muscles as
well as the second heart field (Diogo et al., 2015; Kelly et al., 2004; Lescroart et al., 2015;
Sambasivan et al., 2009). Tbx1 acts together with Myf5 to assure myogenic fate (Harel et al., 2009;
Kelly et al., 2004; Nathan et al., 2008; Sambasivan et al., 2009). In Tbx1-null embryos, the first
pharyngeal arch is hypoplastic and posterior pharyngeal arches do not form, resulting in variably
penetrant defects of masticatory muscles and absence of muscles derived from more posterior
arches including those of the larynx and esophagus (Gopalakrishnan et al., 2015; Heude et al.,
2018; Kelly et al., 2004; Lescroart et al., 2015). Tbx1 exerts cell-autonomous and non-autonomous
roles as conditional deletion of Tbx1 in CPM and pharyngeal endoderm phenocopies the pharyngeal
arch and cardiac outflow tract phenotype of the null mutant (Arnold et al., 2006; Kelly et al., 2004;
Zhang, 2006). On the other hand, the functional role of Isl1 in CPM specification remains unknown
due to early embryonic lethality of Isl1-null mutants (by E10.5) that exhibit cardiac deficiencies
(Cai et al., 2003; Harel et al., 2009; Nathan et al., 2008). Thus, due to the severe phenotypes
observed in the mouse, the epistatic relationship between Tbx1 and Isl1 and their cell-autonomous
roles during CPM-derived muscle specification remain unclear.
Recent studies by us and others showed that CPM progenitors generate diverse myogenic subpo-
pulations at the transition zone between head and trunk (Diogo et al., 2015; Gopalakrishnan et al.,
2015; Heude et al., 2018; Lescroart et al., 2015; Schubert et al., 2019; Tabler et al., 2017).
Whether CPM muscle derivatives form a homogeneous group specified by a unique gene regulatory
network is unknown. We have previously shown that esophagus striated muscles (ESM) arise from
the CPM and exhibit several features that are distinct from other striated muscles in the organism.
Notably, ESM formation initiates in the fetus, thus embryonic myogenesis which generates primary
myofibers that act as scaffolds for secondary (fetal) myofibers does not take place
(Gopalakrishnan et al., 2015). As the esophagus is the only site identified to date that undergoes
this unusual patterning, this raises the issue of what cell type (s) pattern the ESM.
The mammalian esophagus is composed of both striated and smooth muscle layers, which have a
distinct developmental origin (Gopalakrishnan et al., 2015; Krauss et al., 2016; Rishniw et al.,
2003; Zhao and Dhoot, 2000a). Postnatal maturation of the esophagus striated musculature
involves proximo-distal replacement of smooth muscle by as yet elusive mechanisms (Krauss et al.,
2016). Although smooth muscle and other mesenchymal cells are in close proximity to ESM progeni-
tors as they undergo lineage commitment and differentiation, how the latter are patterned in the
absence of primary myofibers remains unknown. It has been proposed that the esophagus smooth
muscle may provide a scaffold for laying down ESM myofibers, however it is unclear to what extent
this differs from other sites in the organism where striated muscles play this role
(Gopalakrishnan et al., 2015; Zhao and Dhoot, 2000a).
Perturbations of esophagus function lead to dysphagia and other pathophysiological disorders
that impair swallowing and transfer of bolus to the stomach (Sheehan, 2008). ESM share a common
origin with branchiomeric head muscles in which Tbx1 and Isl1 act as upstream regulators of myo-
genic specification (Gopalakrishnan et al., 2015; Heude et al., 2018). In Tbx1-null embryos, Isl1-
derived myogenic cells fail to seed the anterior esophagus, suggesting that Tbx1 acts genetically
upstream of Isl1 in ESM progenitors (Gopalakrishnan et al., 2015). Initially, CPM-derived progeni-
tors are seeded at the bottom of the oropharyngeal cavity by E13.5. Then, Isl1-derived ESM progen-
itors colonize the esophagus by posterior migration and differentiation until the third week of
postnatal growth (Gopalakrishnan et al., 2015; Romer et al., 2013). How these Isl1-derived pro-
genitors colonize the structure while restricting premature differentiation remains unknown.
Muscle progenitors undergo short-range displacement or long-range migration for establishing
skeletal muscles, as exemplified by myotomes and limbs, respectively. Progenitors originating from
ventral somites delaminate and emigrate to distal sites to give rise to trunk, limb and tongue
muscles (Bladt et al., 1995; Brand-Saberi et al., 1996; Dietrich et al., 1999). This process is regu-
lated by the tyrosine kinase receptor MET, expressed in migratory progenitors, and its ligand Scatter
Factor/Hepatocyte Growth Factor (SF/HGF) expressed in mesenchymal cells along the migratory
route (Bladt et al., 1995; Brand-Saberi et al., 1996; Dietrich et al., 1999). Knockout of either Met
or Hgf in mice results in the absence of hypaxial muscles including limb muscles, diaphragm and the
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tip of the tongue (Bladt et al., 1995; Dietrich et al., 1999; Maina et al., 1996; Prunotto et al.,
2004). Although second (hyoid) arch-derived muscles are affected in Met KO mice (Prunotto et al.,
2004), a role for MET/HGF signaling in establishing other CPM muscles including those in the larynx
and esophagus has not been reported.
In the present study, we used mouse chimeras to circumvent lethality issues and assess the cell-
autonomous roles of Tbx1 and Isl1 in ESM progenitors. Using genetic loss-of-function and pharma-
cological inhibition approaches, we show that MET/HGF signaling is critical for ESM patterning, but
not for the establishment of adjacent laryngeal muscles. These studies unveil an unexpected Tbx1/
Isl1/Met genetic hierarchy operating within a CPM-muscle group, thereby identifying distinct genetic
signatures for these evolutionarily conserved mesodermal derivatives.
Results
Requirement of Tbx1 and Isl1 in ESM specification
We showed previously that Tbx1-null embryos lack ESM, wherein Isl1-derived myogenic progenitors
fail to colonize and pattern the esophagus (Gopalakrishnan et al., 2015). The absence of seeding of
Isl1-derived ESM progenitors in the anterior esophagus of Tbx1-null mice could originate from cell-
autonomous or non-autonomous defects. To distinguish between these possibilities, we generated
two types of chimeric embryos to explore the epistatic relationship between Tbx1 and Isl1 during
ESM formation. Embryonic chimeras are well-established tools that have provided key insights into
the tissue-specific requirement of genes during mammalian development (Tam and Rossant, 2003).
We first generated chimeras by injection of Isl1lacZ (KI) ES cells (Sun et al., 2007) in Tbx1-/- and
control (Tbx1+/-) blastocysts to determine if Tbx1/Isl1-positive cells can colonize the esophagus in a
Tbx1-null environment. Here, b-galactosidase (b-gal) expression is under the control of the Isl1 pro-
moter to trace the ES-derived cells in vivo (Figure 1—figure supplement 1A,B). All Tbx1-null chime-
ric embryos analyzed between E14.5 and E15.5 lacked thymus glands (n=9) and 77% of them were
edemic and lacked the outer ear pinna indicating that the contribution of Isl1lacZ ES cells (Tbx1wild-
type) was not extensive enough to fully rescue the Tbx1 knockout phenotype (Figure 1—figure sup-
plement 1C,D). Whole mount X-gal staining showed that 5/5 chimeric Tbx1-/- embryos
analyzed contained b-gal+ cells in the esophagus (Figure 1—figure supplement 1E), though to vari-
able extent in individual embryos when compared to heterozygous controls. Apart from its expres-
sion in ESM progenitors, Isl1 is expressed in peripheral neurons (Pfaff et al., 1996) and in the
pharyngeal and esophageal epithelium (Cai et al., 2003; Harel et al., 2009; Nathan et al., 2008).
Therefore, we analyzed tissue sections to assess b-gal expression pattern at the cellular level. We
observed that b-gal+ cells were present within the smooth muscle layers of the esophagus of Tbx1-
null embryos (8/8 chimeras analyzed), and colocalised within Tnnt3+/Tuj1- (myogenic/non-neuro-
genic) cells (Figure 1—figure supplement 1F,G). While ESM colonization in chimeric Tbx1-/-
embryos appeared to be less efficient than in controls (determined by number of b-gal+ cells/section
and Tnnt3+ muscle area/section), the relative number of b-gal+ cells/Tnnt3+ muscle area was non-
significantly altered (Figure 1—figure supplement 1H–J). Taken together, these data indicate that
Isl1lacZ ES cells can colonize an overall Tbx1-null esophageal environment suggesting cell autono-
mous potential of Tbx1+/Isl1+ progenitors to seed and pattern the ESM. Of note, cells expressing
lower levels of b-gal were present in the esophagus epithelia and connective tissue layers of both
control and chimeric Tbx1-null embryos suggesting that, in these cells, expression from the endoge-
nous Isl1 locus was downregulated, and therefore the extent of the contribution of Isl1lacZ ES cells
(Tbx1wildtype) cannot be unambiguously assessed. To circumvent this issue, we generated a second
series of chimeras to address the intrinsic role of Isl1 during fetal esophagus myogenesis.
To bypass the early embryonic lethality of Isl1-null embryos (Cai et al., 2003), we generated chi-
meric fetuses by injection of Isl1-null ES cells into wildtype (WT) mouse blastocysts. We targeted
Isl1-null and control (WT) ES cells with a constitutive lacZ expression cassette (pCAG-nlacZ; nuclear
b-gal activity) to trace ES cell derivatives ubiquitously and independently of Isl1 expression
(Figure 1A–B). Macroscopic examination of chimeras at E16.5 did not reveal obvious developmental
defects in Isl1-null chimeras compared to controls. Immunostainings on sections were then per-
formed to evaluate the contribution of Isl1-null (ES: Isl1-/-; nlacZ) and control (ES: WT; nlacZ) b-gal+
ES-derived cells to the esophagus myogenic population. For reference, contribution of b-gal+ ES-
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derived cells was compared with Isl1 lineage tracing (Isl1Cre/+;R26mT/mG/+ embryos), whereby GFP+
Isl1-derived CPM cells contribute to the esophagus myogenic population (Myod/Myog/Tnnt3+), but
not to the esophagus smooth muscle (SMA+) and striated muscle of tongue that develop in an Isl1-
independent context (Figure 1C–E). We then quantified the percentage of chimerism and
percentage of b-gal+ cells in the esophagus SMA+ and Myod/Myog+ populations and in myogenic
cells of the tongue (n = 3, Figure 1F–K). In both Isl1-null and control chimeras, the overall percent-
age of chimerism in the tongue was similar to that observed in the muscularised layers of the esoph-
agus (Figure 1L–M, left panels). In the esophagus of control chimeras, b-gal+ cells gave rise to both
Figure 1. Cell-autonomous role of Isl1 in esophagus myogenic progenitors. (A) Structures and levels analyzed in
the study. (B) Schematic summary of the chimera experiment. (C–E) Immunostainings on transverse cryosections of
a E18.5 Isl1Cre;R26mTmG fetus for the GFP reporter, Myod/Myog/Tnnt3 (myogenic markers) and SMA (smooth
muscle actin) in the esophagus and tongue. Note that Isl1-derivatives include the esophagus striated muscle but
not the esophagus smooth muscle layers and tongue muscle (n = 2). (F–K) Immunostainings on transverse
cryosections of E16.5 WT (ES: WT;nlacZ) and Isl1-/- (ES: Isl1-/-;nlacZ) chimeras for the b-gal reporter, Myod/Myog
(myogenic markers) and SMA (smooth muscle actin) in the esophagus and tongue (n = 3 each condition). Insets
(bottom, right), higher magnifications. White arrowheads indicate examples of b-gal colocalization with
SMA or Myod/Myog. (L–M) Percentage of chimerism and of b-gal+ cell contribution to the indicated populations
in the esophagus and tongue of WT (ES: WT) and Isl1-/- (ES: Isl1-/-) chimeras (n = 3 each condition, #1–3; three
different section levels scored). The total number of cells counted on three different section levels are reported in
columns. Note that the Isl1-/- ES-derived cells do not form ESM progenitors but contribute to both esophagus
smooth muscle layers and tongue. Scale bars: C, 100 mm; K, 50 mm.
DOI: https://doi.org/10.7554/eLife.47460.002
The following figure supplement is available for figure 1:
Figure supplement 1. Isl1nlacZ/+ cells colonize the esophagus of chimeric Tbx1 mutants.
DOI: https://doi.org/10.7554/eLife.47460.003
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SMA+ (31–46%) and Myod/Myog+ populations (25–43%) (Figure 1F,G,L). In contrast, Isl1-null/b-gal
+ cells were excluded from the esophagus Myod/Myog+ cells (Figure 1I,J,L), whereas they contrib-
uted to a similar extent to esophagus smooth muscle and tongue myogenic cells in both Isl1-null
and control chimeras. These results show that Isl1 is necessary cell-autonomously for progenitor cells
to adopt a myogenic cell fate in the esophagus (Figure 1B).
Spatiotemporal activation of the ESM myogenic program
ESM development occurs in a biphasic mode, with initial seeding of Isl1-positive myogenic progeni-
tors at the anterior esophagus followed by anterior-posterior migration and differentiation that pro-
ceeds to postnatal stages (Gopalakrishnan et al., 2015). Isl1 is known to maintain cells in an
undifferentiated state in branchiomeric muscle progenitors (Cai et al., 2003; Nathan et al., 2008).
To determine the expression level of Isl1 in ESM progenitors relative to lineage committed MRF
Figure 2. Regulation of esophagus striated muscle patterning involves MET/HGF signaling. (A–C) RT-qPCR
analysis for Isl1 and Myf5 at E15.5 (A), E17.5 (B) and 3 weeks postnatal (C) in different esophagus portions and
stomach as indicated in the schematic view (top, right). The low level of Isl1 expression in the posterior esophagus
at fetal stages might reflect contamination from the stomach at the esophagus interface (n = 3 each condition).
(D–E) RT-qPCR analysis for Isl1 and Met at E15.5, E17.5 and 3 weeks postnatal in Tg:Pax7-nGFP+ cells isolated by
FACS from the masseter or esophagus. All data points are plotted and presented as the mean ± SEM (error bars)
(n = 3 each condition). (F–H) Immunostainings on transverse cryosections of E16.5 control, MetD/D and Hgf-/-
fetuses for Myod/Myog (myogenic progenitors) and SMA (smooth muscle actin). E-Cad labels the esophagus
lumen epithelium. Higher magnifications are shown in (F’–H’) (n = 3 each condition). (I–K) Immunostainings on
transverse cryosections of E16.5 control, MetD/D and Hgf-/- fetuses for Tnnt3 (myofiber marker) and E-Cad. Higher
magnifications are shown in (I’–K’). Note the absence of ESM formation in both Met and Hgf mutants (n = 3 each
condition). Scale bars: F, 100 mm; F’, 50 mm.
DOI: https://doi.org/10.7554/eLife.47460.004
The following figure supplements are available for figure 2:
Figure supplement 1. Met and Hgf expression along the developing esophagus.
DOI: https://doi.org/10.7554/eLife.47460.005
Figure supplement 2. Phenotype of Met and Hgf mutants.
DOI: https://doi.org/10.7554/eLife.47460.006
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genes, we performed RT-qPCR analysis at key stages of ESM development: at E15.5 and E17.5
when one third and two thirds of the esophagus is populated by ESM progenitors, respectively; then
at 3 weeks postnatally when the entire esophagus is muscularised. Isl1 and Myf5 transcripts were
detected in the anterior, middle and posterior esophagus as ESM progenitors colonize the structure
from E15.5 to 3 weeks postnatally (Figure 2A–C). Isl1 expression was also detected in the stomach,
as already described for the gastric epithelium (Das and May, 2011). We next performed RT-qPCR
analysis for Isl1 in myogenic cells isolated from Tg:Pax7-nGFP mice where Pax7+ progenitors can be
isolated from mid-embryonic stages (Sambasivan et al., 2009) (Figure 2D). Isl1 was expressed in
Pax7-nGFP+ esophagus progenitors, whereas expression was low or undetectable in those isolated
from the masseter at all stages analyzed. Therefore, Isl1 expression is maintained in myogenic pro-
genitors throughout ESM development.
We then asked what molecular pathways would guide ESM progenitors to undergo A-P migra-
tion. Given the key role for MET/HGF signaling during delamination and long distance migration of
hypaxial muscle progenitors (Bladt et al., 1995; Dietrich et al., 1999; Maina et al., 1996;
Prunotto et al., 2004), we performed RT-qPCR analysis for Met in isolated Pax7-nGFP+ myogenic
cells of the esophagus, as well as for Met, Hgf and SMA (as a landmark for the smooth muscle scaf-
fold) in anterior, middle and posterior whole esophagus portions. Notably, Pax7-nGFP+ ESM pro-
genitors showed transcript abundance of Met at fetal stages and lower expression levels postnatally
when ESM colonization was complete (Figure 2E). Along the anterior-posterior axis, Met levels were
higher in the anterior esophagus portion at E13.5 and E15.5, and become upregulated also in the
middle part by E17.5 (Figure 2—figure supplement 1A). Hgf levels seemed initially constant along
the esophagus length at E13.5, but appeared downregulated anteriorly in parallel with SMA at later
stages (Figure 2—figure supplement 1B,C). Taken together, these data suggest that MET/HGF sig-
naling might be implicated in A-P migration of ESM progenitors from fetal to postnatal stages.
Severe loss of ESM in Met and Hgf mutants
To address the role of MET/HGF signaling during ESM formation, we examined MetD/D and Hgf-null
mutants (Maina et al., 1996; Schmidt et al., 1995). We first analyzed the esophagus phenotype of
Met and Hgf mutants at E16.5 by immunostainings on tissue sections for early myogenic and myo-
fiber markers (Myod/Myog/Tnnt3), for smooth muscle (SMA) and lumen epithelium (E-Cad) markers.
Interestingly, MetD/D and Hgf-null fetuses showed absence of striated muscles in the esophagus,
while the smooth muscle layers and lumen epithelium appeared unaffected (Figure 2F–K). As
expected, these mutants lacked limb muscles typical of the MetD/D and Hgf-null phenotypes (Fig-
ure 2—figure supplement 2A–F). However, RT-qPCR analysis in the esophagus and limb of Met
mutants at E15.5 revealed a decrease but not loss of Isl1 and Myf5 expression compared to absence
of Pax7 and Myf5 observed at limb level (Figure 2—figure supplement 2G).
Given this observation, we investigated whether myogenic cells are present at the anterior-most
part of the esophagus and in adjacent Isl1-derived muscles in the MetD/D fetuses (Figure 3A–C).
Analysis on tissue sections revealed that the number of Isl1+ cells in the upper esophagus of E13.5
controls and Met mutants was not significantly different (n = 3) (Figure 3A–B’, Figure 3—figure sup-
plement 1A–A’’). Thus, the myogenic progenitors had seeded the anterior esophagus in mutant
embryos similarly to controls at this initial stage. Moreover, analysis of MetD/+ ; Myf5nlacZ/+ (control)
and MetD/D ; Myf5nlacZ/+ (mutant) esophagi at E15.5 (Figure 3—figure supplement 1B,C) and E17.5
(Figure 3D,E; Figure 3—figure supplement 1D,E) showed that Myf5+ myogenic cells were also
present in the anterior-most portion of the esophagus in the mutant, whereas colonization had pro-
ceeded posteriorly only in the controls. Of note, the neuronal and smooth muscle lineages were
present and patterned in mutants (Figure 3D,E).
Next, we investigated the fate of the sporadic myogenic cells remaining in the anterior esophagus
of Met-null fetuses. To this end, we combined the MetD/D mutant with Isl1 lineage tracing. Analysis
of E14.5 MetD/+; Isl1Cre/+;R26mT/mG/+ control embryos showed that mGFP+ mononucleated cells
were abundant in between myofibers (Figure 3F). However, very few mononucleated mGFP+ cells
were detected between the residual myofibers in the anterior-most part of the esophagus in the
Met mutant (Figure 3G). Strikingly, the adjacent Isl1-derived laryngeal and pharyngeal muscles were
unaffected in the Met-null fetuses (Figure 3C,C’,D–G; Figure 3—figure supplement 1B–E). There-
fore, these observations indicate that MET/HGF loss of function affect only a subset of posterior
CPM-derived progenitors that are critical for colonization of the esophagus but not for the
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development of adjacent Isl1-lineage-derived muscles. Taken together, these results indicate that
Met acts downstream of Isl1 in the molecular hierarchy of ESM formation and that MET/HGF signal-
ing is not implicated in initial seeding of Isl1-derived progenitors in the anterior esophagus, but
rather during the second phase of myogenic migration. This is in agreement with the biphasic mode
of ESM development postulated previously (Gopalakrishnan et al., 2015).
Figure 3. Isl1 progenitors are present anteriorly in the esophagus of MetD/D mutants. (A) Structures and levels
analyzed in the study. (B,B’) Immunostainings on transverse cryosections of E13.5 control and MetD/D embryos for
Isl1 expressing progenitors (white arrowheads) and smooth muscle cells (SMA) in the esophagus (n = 2). (C,C’)
Immunostainings on transverse cryosections at the laryngeal level of E13.5 control and MetD/D embryos for Pax7
(n = 2). (D–G) Whole mount immunostaining of the upper esophagus of Met mutant and control embryos. (D,E)
Ventral views of E17.5 esophagi stained for Tuj1 (neurons), SMA (smooth muscle actin) and b-gal (Myf5nlacZ
reporter positive progenitors). White-dotted lines outline the shape of the esophagus entry. White arrowheads
point to Myf5nlacZ/+ progenitor cells present in the upper esophagus in the mutant. (F,G) Dorsal views of E14.5
stained for GFP (Isl1 lineage tracing). Isl1-derived muscle progenitors remain largely as mononucleated cells in the
control (F,F’, white arrowheads) while GFP+ fibers are mostly seen in the anterior esophagus of the mutant (G,G’,
arrows) (n = 2 each condition). cp, cricopharyngeous muscle; epi, epithelial Isl1-derived cells; esm,
esophagus striated muscle; lgm, laryngeal muscles; pc, pharyngeal constrictor. Scale bars: B’, C’, F’, 50 mm; D, F,
200 mm.
DOI: https://doi.org/10.7554/eLife.47460.007
The following figure supplement is available for figure 3:
Figure supplement 1. Myogenic cells are present anteriorly in the esophagus of MetD/D mutants.
DOI: https://doi.org/10.7554/eLife.47460.008
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Requirement of MET/HGF signaling for A-P migration of ESM
progenitors
To rule out the possibility that the defect in ESM formation in Met mutants is due to increased cell
death in the anterior-most portion of the esophagus as opposed to aberrant migration of ESM cells,
we tested if Isl1+ progenitors undergo apoptosis at the seeding stage in Met mutant embryos.
TUNEL analysis in E13.5 controls and Met mutants revealed that Isl1+ progenitors in the upper
esophagus were not apoptotic at this stage (Figure 4—figure supplement 1A,A’).
Next, we investigated the role of MET in the migration of mGFP+ cells in an ex vivo esophagus
explant culture system once they had colonized the upper esophagus (Figure 4A). To this end, we
employed static cultures and time-lapse confocal microscopy on E14.5 Isl1Cre;R26mT/mG esophagus
in combination with two selective ATP-competitive inhibitors of MET, PF-0417903 and MGCD-265
or DMSO as control (Figure 4B–D). On control static cultures (followed up to 24 hr) and time-lapse
imaging (up to 14 hr), we observed a mGFP+ mononucleated cell front that remained throughout
the entire culture period (Figure 4—figure supplement 1B, Figure 4B, Figure 4—video 1). In addi-
tion, time-lapse movies showed that mGFP+ cells explored the esophagus scaffold repeatedly
changing their direction of migration, but had a net movement posteriorly towards the stomach
(Figure 4E, Figure 4—video 1). Upstream of the mononucleated cell front, mGFP+ cells also
migrated posteriorly in between forming fibers (Figure 4—video 1). In contrast, upon addition of
MET inhibitors, mGFP+ cells progressed less towards the posterior end (Figure 4C,D, Figure 4—
videos 2 and 3) and had shorter cell trajectories (Figure 4F–H). Quantification of migration parame-
ters revealed that in presence of MET inhibitors, mGFP+ cells had a reduced velocity,
displacement, efficiency, and net velocity compared to control cultures (Figure 4I–L). Interestingly,
mGFP+ fibers appeared rapidly in the inhibitor treated cultures in positions where the cell density
appeared higher (Figure 4C,D, Figure 4—figure supplement 1C), a phenotype that resembled
Met-null embryos (Figure 3G, Figure 3—figure supplement 1E). To confirm this, we examined the
proliferation and differentiation status of ESM myogenic cells in vivo by EdU labelling. Analysis of
E14.5 and E15.5 embryos showed that myogenic cells in the esophagus of MetD/D mutant embryos
have a proliferation rate that was one third of controls (45,6% for Ctrl; 12,5% for Mutant at E14.5,
Figure 4—figure supplement 1D) and a higher predisposition to differentiation as assessed by
Myogenin expression (33% for Ctrl; 66% for Mutant at E14.5, Figure 4—figure supplement 1E).
In summary, our ex vivo and in vivo analyzes indicate that MET/HGF signaling promotes A-P
migration of ESM myogenic progenitors during fetal development and possibly maintains Isl1-
derived progenitors in an undifferentiated state once they have colonized the upper esophagus.
Cellular relationships of Isl1 and Met/Hgf expression in ESM
progenitors
We then decided to examine in detail the expression pattern of Hgf and Met in relation to Isl1-
derived progenitors. Owing to the limited diffusion efficiency of HGF in vivo, both receptor and
ligand expressing cells are expected to be found in close proximity to each other (Dietrich et al.,
1999). Whole mount in situ hybridization (RNAscope) on Isl1Cre;R26mT/mG embryos showed that Hgf
transcripts were present along the entire length of the esophagus, preceeding and following the
myogenic cell front, at the seeding stage (E13.5) and during myogenic migration (E14.5) (Figure 5—
figure supplement 1A,B). In situ hybridization on sections revealed that Hgf was expressed adjacent
to mGFP+ cells in a bilayered concentric pattern overlapping with the smooth muscle layers of the
esophagus (Figure 5A,B; Figure 5—figure supplement 1). Initially at E14.5, although a bilayered
pattern of Hgf is observed, myogenic cells colonized exclusively the outer smooth muscle layer
(Figure 5A). At E16.5, expression of Hgf appeared to be downregulated anteriorly in the outer layer
(level 1; Figure 5—figure supplement 1E), concomitant with the described regression of smooth
muscle in the anterior esophagus from late fetal stages (Figure 2—figure supplement 1B–C)
(Zhao and Dhoot, 2000a). At this stage, myogenic cells started to colonize the inner layer anteriorly
(Zhao and Dhoot, 2000b), and this corresponded to downregulation of Hgf expression in the outer
layer (Figure 5—figure supplement 1E–E”). Quantifications of the amount of Hgf transcripts per
smooth muscle area corroborated these observations and revealed uniform levels between the myo-
genic cell front and more posterior levels (E13.5 and E14.5, levels 1–3; E16.5, levels 2–4; Figure 5—
figure supplement 1F). Altogether, our data indicate that the smooth muscle layers of the
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Figure 4. MET/HGF signaling is required for migration of Isl1-derived myogenic progenitors. (A) Macroscopic view
of Isl1Cre;R26mT/mG E14.5 dissected esophagus used for explant culture and live imaging. Esophagi were placed in
collagen beds in individual Ibidi wells. MET inhibitors (MGCD-265, PF-0417903) or control (ctrl, DMSO) were
added to explants 30 min before imaging. Explants were kept for 14 hr for live imaging (with an image taken every
12–15 min) or 24 hr for analysis at fixed time points (Figure 4—figure supplement 1). (B–D) Maximum projection
of time series from a time-lapse experiment of esophagi explant culture in the presence of DMSO (B), 10 mM PF-
0417903 (C) or 10 mM MGCD-265 (D). White arrowheads point to Isl1-derived progenitor cells present at the
mononucleated cell front (mcf). White arrows highlight the high numbers of fibers that appear progressively in the
inhibitor condition. Time (t) is indicated in hours. Dotted lines show the overall advancement of the mcf in the
control condition. (E–H) Temporal color coded 2D images of GFP+ cell trajectories tracked in the time lapse
movies in control and inhibitor treated explant cultures (related to Figure 4—videos 1, 2 and 3). (I–L)
Figure 4 continued on next page
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esophagus are the major source of Hgf for anterior-posterior migration of myogenic progenitors. As
such, this Hgf dynamic pattern might contribute to myogenic cell progression from the outer to inner
layer, and anterior to posterior levels.
In turn, Met was expressed at high levels anteriorly in Isl1-derived mGFP+ myogenic cells, and
also in luminal epithelial cells (Figure 5C, Figure 5—figure supplement 1G,H). However, the levels
of Met transcript in mGFP+ cells were heterogeneous. Co-immunostaining with Myod and Myog
antibodies to detect differentiating myogenic cells, revealed that 34% of mGFP+ cells were Myod+/
Myog+ and that 74% of these Myod+/Myog+ cells had low levels of Met transcript (score 0 and 1;
Figure 5C1,C2,D,E). Conversely, 91% of the Myod-/Myog- cells, expressed high levels of Met (score
3 and 4) (Figure 5C1,C2,E). Therefore, expression of Met was inversely correlated with the differen-
tiation status of Isl1-derived cells.
To investigate the relative expression status of these myogenic markers in more detail, we per-
formed single cell RT-qPCR analysis of Isl1-derived ESM progenitors. The mononucleated cell front
in the esophagus of E15.5 Isl1Cre;R26mT/mG mice was dissected and the expression of myogenic
markers was examined in mGFP+ isolated by fluorescence-activated cell sorting (FACS) (Figure 5—
figure supplement 2A). The normalized relative expression of the studied genes for all the filtered
cells was annotated in a heatmap (Figure 5—figure supplement 2B) and revealed two groups of
genes. The first group included Isl1, Met, Pax7 and Myf5 which were detected in nearly all the single
cells analyzed. The second group included Mrf4, Myog and Myod which were expressed in a subset
of cells. To assess the degree of relatedness between genes, we calculated the Spearman’s correla-
tion between all pairs of genes and noted that the expression of Isl1, Met, Pax7 and Myf5 was signif-
icantly positively correlated (Figure 5F). In contrast, Isl1 expression showed no significant correlation
with the expression of more downstream MRF genes (Myod, Myog, and Mrf4). This indicates that
Isl1 is associated with the upstream state, and that Isl1 and Met likely act concomitantly in myogenic
progenitors during ESM formation.
Discussion
In vertebrates, branchiomeric head and neck muscles share a common CPM progenitor pool regu-
lated by upstream molecular players including Tbx1 and Isl1. Here, we uncover a cell-autonomous
requirement of Tbx1 and Isl1 in the specification of CPM-derived esophagus myogenic progenitors.
In addition, we show for the first time a unique dependency of myogenic progenitors on MET/HGF
signaling pathway for esophagus spatio-temporal patterning. Surprisingly, laryngeal muscles that
Figure 4 continued
Quantification of cell velocity (in mm/min; I), displacement (mm, the length of the resultant vector between ti and tf
of the track; J), efficiency (ratio between the displacement and the distance covered by the whole track; K), net
velocity (mm/min, ratio between the displacement and total time of the track; L) in control and inhibitor treated
explant cultures. Dots, individual cells tracked (from n = 2 experiments containing control and inhibitor
treatments). Mean ± SEM. Statistical significance was assessed by a Mann-Whitney test. pc, pharyngeal constrictor.
Scale bar: D, 100 mm.
DOI: https://doi.org/10.7554/eLife.47460.009
The following video, source data, and figure supplement are available for figure 4:
Source data 1. This. zip file contains excel tables with the individual tracking parameters.
DOI: https://doi.org/10.7554/eLife.47460.011
Figure supplement 1. Met invalidation does not affect the proliferation and survival of Isl1 progenitors.
DOI: https://doi.org/10.7554/eLife.47460.010
Figure 4—video 1. Time-lapse movie of a control E14.5 Isl1Cre;R26mT/mG esophagus explant culture.
DOI: https://doi.org/10.7554/eLife.47460.012
Figure 4—video 2. Time-lapse movie of a E14.5 Isl1Cre;R26mT/mG esophagus explant culture treated with 10 mM
PF-0417903.
DOI: https://doi.org/10.7554/eLife.47460.013
Figure 4—video 3. Time-lapse movie of a E14.5 Isl1Cre;R26mT/mG esophagus explant culture treated with 10 mM
MGCD-265.
DOI: https://doi.org/10.7554/eLife.47460.014
Comai et al. eLife 2019;8:e47460. DOI: https://doi.org/10.7554/eLife.47460 10 of 27
Research article Developmental Biology Evolutionary Biology
also originate from the posterior pharyngeal arches are unaffected in Met mutants, thereby uncou-
pling the genetic requirements between ontogenically similar groups of CPM-derived muscles.
These findings highlight distinct genetic hierarchies operating with CPM derivatives, and provide a
framework to address myopathies of branchiomeric origin (Figure 6).
Cell-autonomous role of Isl1 during esophagus myogenesis
Recent genetic studies revealed that neck muscles including pharyngeal and laryngeal muscles, the
trapezius and the esophagus originate from posterior pharyngeal arch mesoderm derived from an
Isl1-lineage (Gopalakrishnan et al., 2015; Heude et al., 2018; Lescroart et al., 2015; Tabler et al.,
2017). We previously demonstrated that Tbx1 and Isl1 genes play key upstream roles during ESM
formation (Gopalakrishnan et al., 2015). In Tbx1-null embryos, Isl1-derived ESM fail to form, indicat-
ing that Tbx1 acts upstream of Isl1 during esophagus myogenesis (Gopalakrishnan et al., 2015).
Given that Isl1 promotes cell proliferation and represses myogenic differentiation, Isl1 has been pro-
posed to exert a conserved role in the specification of CPM progenitors (Cai et al., 2003;
Diogo et al., 2015; Harel et al., 2009). However, the intrinsic role of Isl1 in CPM derivatives has not
been addressed due to early embryonic lethality (Cai et al., 2003). Here, by means of chimeric anal-
ysis, we show that Isl1-null ES cells are specifically excluded from the ESM indicating that Isl1 acts
cell-autonomously during ESM formation at fetal stages, further supporting its role in the specifica-
tion of branchiomeric myogenic progenitors.
MET/HGF signaling drives anterio-posterior migration of esophagus
muscle progenitors
During development, positional information that includes migration cues is often imparted to cells
through intercellular signaling to allow proper spatio-temporal patterning. Several studies have
uncovered the role of MET receptor and its ligand HGF in the proliferation and long-range migration
of myogenic progenitors (Trusolino et al., 2010). The Met allele used here (MetD) carries a mutation
in two phosphotyrosines (Tyr1349, Tyr1356) in the carboxy-terminal tail, which completely abrogates
MET function and recapitulates the Met null phenotype (Bladt et al., 1995; Maina et al., 1996;
Maina et al., 2001). Previous work showed that in Met and Hgf mutants, Pax3-derived hypaxial
muscles are missing, while other epaxial trunk muscle groups appear unaffected (Bladt et al., 1995;
Dietrich et al., 1999; Maina et al., 1996; Prunotto et al., 2004).
In the trunk, Hgf is first expressed adjacent to somites, and subsequently along the migratory
route and at target sites in limb connective tissue (Dietrich et al., 1999). In the esophagus, we iden-
tified the smooth muscle layer, which serves as a scaffold for myogenic progenitor migration, to be a
major source of Hgf. This finding is in agreement with a recent study showing that HGF is mainly
localized in smooth muscle cells in endodermal organs including the stomach and esophagus
(Jangphattananont et al., 2019). Thus, our data highlight the functional coordination between adja-
cent but distinct smooth and striated muscle progenitors that facilitate ESM patterning which is
unique compared to muscle patterning elsewhere.
How HGF levels are precisely controlled in the ESM developmental context to allow A-P muscle
progenitor cell migration is unknown. In the limb, Hgf transcripts retreat in the subectodermal
region, but a proximo-distal Hgf transcript gradient along the migration route of Met+ myogenic
progenitors is not clearly observed (Birchmeier and Gherardi, 1998; Bladt et al., 1995;
Dietrich et al., 1999; Yang et al., 1996). In the ESM, we observed by in situ hybridization on whole
mount and sections that Hgf is expressed throughout the length of the esophagus at the time of
seeding (E13.5) and ongoing migration (E14.5, E16.5) in a bilayered pattern. Unexpectedly, we
observed seemingly constant transcript levels between the migratory front and more posterior levels
raising the question of how directed migration is promoted. Interestingly, we observed by qRT-PCR
and in situ hybridization that Hgf levels are diminished anteriorly in the outer layer at fetal stages,
upstream to the front, concomitant with a decrease in SMA transcript and protein levels. Thus, it is
possible that a gradient for migration is established by a decrease of Hgf source anteriorly, given
the decrease in size and number of smooth muscle cells that occurs cranially from fetal stages
(Zhao and Dhoot, 2000a). The fate of smooth muscle cells has been debated, nevertheless a combi-
nation of cell loss and distal compaction of smooth muscle cells, appear to be contributing factors
(Krauss et al., 2016; Rishniw et al., 2007). Thus, the observed Hgf dynamics with respect to the
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Figure 5. Met is expressed in undifferentiated Isl1-derived myogenic progenitors. (A–C) In situ hybridization on
transverse cryosections at the esophagus level of E14.5 Isl1Cre;R26mTmG embryos for Hgf (A, B) and Met (C),
combined with immunofluorescence for GFP (Isl1-derived progenitors), SMA (smooth muscle actin) and Myod/
Myog (myogenic cells) (shown in A’-C’). Note that Hgf is expressed adjacent to Isl1-derived cells (A1,A2) by SMA+
cells (B1,B2). Met is expressed by Isl1-derived cells but at levels inversely correlated to Myod/Myog+ expression
(C1, C2, channels split for clarity). Note that Isl1-derived myogenic cells are exclusively present in the outer layer at
this stage. (D) Histograms of the percentage of Myod/Myod- and Myod/Myog+ Isl1-derived GFP+ cells. (E)
Histograms of the percentage of cells in (D) with a defined RNAscope score for Met expression. n = 3 embryos,
with a minimum of 3 sections at the anteriormost part of the esophagus per embryo. A total of 368 GFP+ cells
were assessed for the expression of Myod/Myog (D) and RNAscope score. (F) Correlogram. The upper part of the
mixed correlogram displays graphically the degree of relationships between genes. The bigger the circle, the
higher the Spearman’s correlation coefficient; the redder, the more negative; the bluer, the more positive. The
lower part shows the values of the Spearman’s coefficient. il, inner layer ; ol, outer layer. Scale bars: A, A2, 20 mm.
DOI: https://doi.org/10.7554/eLife.47460.015
Figure 5 continued on next page
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localization of myogenic cells are in agreement with the outer to inner layer and anterior to posterior
myogenic cell progression (Zhao and Dhoot, 2000a; Zhao and Dhoot, 2000b).
In addition to transcriptional control, directional migration may also rely on a gradient of active
two-chain HGF heterodimer. HGF bioavailability depends on a number of factors including HGF acti-
vators and inhibitors that exert essential roles during embryonic development and muscle regenera-
tion (Rodgers et al., 2017; Sisson et al., 2009; Tanaka et al., 2005; van Adelsberg et al., 2001)
and heparin sulfate proteoglycans that can enhance MET/HGF signaling (Gutie´rrez et al., 2014). In
addition, myogenic cells at the migratory front might sequester active HGF, thereby limiting its bio-
availability. As such, net caudal movement could result from a self-generated localized signaling gra-
dient as has been observed in other developmental contexts (Cai and Montell, 2014).
In our time-lapse movies, we noted that Isl1-derived progenitors navigate the esophageal scaf-
fold, switching directions, but with a net caudal displacement as differentiated myofibers are depos-
ited in its wake. Thus, another possibility is that HGF does not act as a directional migration cue, but
rather maintains ESM myogenic progenitors in a scattered status to reach a ‘myogenic free’ zone.
The functional validation for these diverse scenarios awaits further investigation.
Met regulation underlies esophagus myogenic patterning
It has been proposed that a prolonged interaction between MET and HGF may be required to pre-
vent cell re-aggregation, thereby maintaining cell motility and preventing expression of the MRFs
(Dietrich et al., 1999). The first obvious deficiency observed in MetD/D embryos is seen at the time
Isl1+ progenitors colonize the smooth muscle scaffold (by E14.5). In controls, colonization pro-
gresses posteriorly and myofibers are formed while maintaining a pool of progenitor cells. In the
mutant, only few Isl1-derived myofibers are present in the upper esophagus. Similarly, our pharma-
cological inhibition studies of MET receptor activity in esophagus explants resulted in impaired pro-
genitor cell migration and precocious differentiation. Thus, MET/HGF signaling might have a role in
maintenance of the undifferentiated state of migratory muscle progenitors to allow continuous pro-
gression of the myogenic front. It remains unclear if motility prevents or delays expression of the dif-
ferentiation genes, or if expression of differentiation genes stops motility. However, it has been
shown that precocious expression of MRFs in dermomyotomal muscle progenitors prevents their
migration into limb buds (Bonnet et al., 2010), while application of HGF results in reduction of
Myod expression (Scaal et al., 1999).
During limb muscle development, the Met receptor was reported to be under the direct tran-
scriptional regulation of Pax3 (Epstein et al., 1996). Interestingly, ESM development requires MET/
HGF signaling in a Pax3-independent context. Hence the upstream modulator of Met expression in
ESM progenitors remains an open question. Pax3 and its paralog Pax7 have partially redundant func-
tions in muscle progenitors (Relaix et al., 2006). Given that common Pax3/Pax7 binding sites are
found in Met regulatory regions in adult limb primary myoblasts (Soleimani et al., 2012), Pax7 could
exert such a role in ESM progenitors. Interestingly, Pax7 knockout mice develop megaesophagus
postnatally with striated muscle present in an abnormally proximal position (Chihara et al., 2015).
Whether this impairment in ESM formation is solely due to reduced proliferation and precocious dif-
ferentiation at the migratory front, or is concomitant to a reduced expression of MET is currently
Figure 5 continued
The following source data and figure supplements are available for figure 5:
Source data 1. Excel table containing individual countings from three independent experiments to generate the
histograms in panels 5D-E.
DOI: https://doi.org/10.7554/eLife.47460.018
Source data 2. This folder contains the initial single cell count matrix of the Ct values (tab2_3_sc_edge_allGe-
nes_Ct.R), and the R source code (eso_t2_t3__analysis.R) used to filter, log-transformed, normalized, calculate the
correlation coefficient and generate the correlogram on this figure.
DOI: https://doi.org/10.7554/eLife.47460.019
Figure supplement 1. Expression domains of Hgf and Met along the developing esophagus.
DOI: https://doi.org/10.7554/eLife.47460.016
Figure supplement 2. Esophagus single cell analysis.
DOI: https://doi.org/10.7554/eLife.47460.017
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unknown. On the other hand, our in situ hybridization and single cell qPCR data showed that Isl1,
Pax7 and Met are predominantly co-expressed in uncommitted ESM progenitors (Pax7+, Myf5+,
Myod/Myog-), with decreased expression in committed cells. This observation is in agreement with
the known role of Isl1 as negative regulator of muscle differentiation of CPM-derived muscles
(Harel et al., 2009). It remains unclear if Isl1 also exerts a direct role in motility by regulation of Met.
Interestingly, Isl1-Lhx3 fusion protein was shown to induce Met expression in motor neurons
(Lee et al., 2012). Intriguingly, several putative Lhx binding sites including consensus Isl1-binding
sites (cTAATg) were identified by in silico analysis of Met promoter elements using matinspector
(Cartharius et al., 2005) (data not shown). It is therefore tempting to speculate a direct regulation
of Met expression by Isl1.
Figure 6. Tbx1-Isl1-Met genetic pathway regulates only a subset of CPM-derived muscles. (A) Masticatory (purple)
and facial (blue) muscles originating from anterior pharyngeal arches (PA1-2) are indicated. Neck muscles (green)
derived from posterior PAs including trapezius, pharyngeal and laryngeal muscles, develop in a Met-independent
context, while esophagus striated muscles are under the control of MET/HGF signaling. (B) A Tbx1/Islet1/Met
genetic hierarchy acts in uncommitted ESM progenitors. Then, Met expression decreases in myoblasts during
myogenic commitment. (C) Absence of ESM formation in the Met and Hgf mutants. CPM, cardiopharyngeal
mesoderm; bc, buccinator; e, esophagus; esm, esophagus striated muscles; lgm, laryngeal muscles; ms, masseter;
oo, orbicularis oculi; PA1-6, pharyngeal arches 1–6; pc, pharyngeal constrictor; pl, platysma; st, stomach; te,
temporal; tpm, trapezius muscles.
DOI: https://doi.org/10.7554/eLife.47460.020
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Finally, a hierarchy in lineage progression could be inferred from phenotypes of mutant mice
(Krauss et al., 2016). The myogenic front in the Pax7 knockout esophagus is localized more posteri-
orly than what we observed in Met-null embryos (Chihara et al., 2015). This suggests a possible
temporal regulation of Met expression in ESM progenitors by Isl1 in the fetus, preempted by Pax7 in
postnatal stages, and likely facilitated by temporally controlled transcriptional coactivators. Taken
together, these observations warrant further studies including genome-wide ChIP-seq to explore if
Pax7 and/or Isl1 directly regulate Met expression.
Myogenic diversity within CPM-derived muscles
An unexpected finding from our work is that CPM muscles originating from posterior pharyngeal
arches are differentially affected in Met mutants. Head muscles derived from the second pharyngeal
arch and giving rise to branchiomeric facial muscles (orbicularis oculi, buccinator, platysma) appear
either strongly reduced or absent, while first arch-derived masticatory (masseter, temporalis) and
extraocular muscles are present in MetD/D mutants (Prunotto et al., 2004). However, we show that
posterior branchiomeric neck muscles, including pharyngeal and laryngeal muscles, are present in
MetD/D mutants while adjacent ESM is absent. Thus, we have established a unique Tbx1-Isl1-Met
genetic hierarchy in ESM progenitors that is distinct from other posterior branchiomeric muscles
(Figure 6).
The genetic regulatory pathways that give rise to functionally distinct groups of muscles has pro-
vided critical information to understand heterogeneity in response to genetic diseases, such as
DiGeorge syndrome where mutations in TBX1 result in the impaired function of subsets of craniofa-
cial and pharyngeal apparatus with varied degrees of severity. Understanding the functional dynam-
ics of Tbx1 and Isl1 in specific muscles groups will help uncover differences between the
ontogenically similar subsets of CPM-derived muscles. Uncoupling the genetic requirements of these
distinct populations is necessary to provide a framework that will explain how human myopathies
affect only subsets of muscles (Emery, 2002; Randolph and Pavlath, 2015).
Materials and methods
Key resources table
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Strain, strain
background
(Mus musculus)
B6D2F1/JRj Janvier
Genetic
reagent
(M. musculus)
Islet1Cre PMID:11299042 MGI:2447758 Dr. Thomas M Jessell
(Howard Hughes Medical
Institute, Columbia
University, USA)
Genetic
reagent
(M. musculus)
Myf5nlacZ PMID:8918877 MGI:1857973 Dr. Shahragim Tajbakhsh
(Department of
Developmental and
Stem Cell Biology,
Institut Pasteur, France)
Genetic
reagent
(M. musculus)
Tg :Pax7-nGFP PMID:19531352 MGI:5308730 Dr. Shahragim Tajbakhsh
(Department of
Developmental and
Stem Cell Biology,
Institut Pasteur, France)
Genetic
reagent
(M. musculus)
R26mT/mG PMID:17868096 MGI:3716464 Pr. Philippe Soriano
(Icahn School of
Medicine at Mt. Sinai, USA)
Genetic
reagent
(M. musculus)
Hgf KO PMID:7854452 MGI:1857656 Pr. Carmen Birchmeier
(Max Delbruck Center
for Molecular Medicine,
Germany)
Continued on next page
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Continued
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Genetic
reagent
(M. musculus)
MetD PMID:8898205 MGI:1858019 Pr. Carola Ponzetto
(Department of Molecular
Biotechnology,
University of Turin, Italy)
Genetic
reagent
(M. musculus)
Tbx1KO PMID:11242110 MGI:2179190 Dr. Virginia Papaioannou
(Department of Genetics
and Development,
Columbia University
Medical Center, USA)
Antibody Chicken polyclonal
anti-b-gal
Abcam Cat. #: ab9361
RRID:AB_307210
IF (1:1000)
Antibody Rabbit polyclonal
anti-b-gal
MP Biomedicals Cat. #: MP 559761
RRID:AB_2687418
IF (1:1500)
Antibody Chicken polyclonal
anti-GFP
Aves Labs Cat. #: 1020
RRID:AB_10000240
IF (1:500)
Antibody Chicken polyclonal
anti-GFP
Abcam Cat. #: 13970
RRID:AB_300798
IF (1:1000)
Antibody Mouse monoclonal
IgG1 anti-Islet1
DSHB Cat. #: 40.2D6
RRID:AB_528315
IF (1:1000)
Antibody Mouse monoclonal
IgG1 anti-Desmin
Dako Cat. #: ab8470
RRID:AB_306577
IF (1:100)
Antibody Mouse monoclonal
IgG1 anti-Myod
Dako Cat. #: M3512
RRID:AB_2148874
IF (1:100)
Antibody Mouse monoclonal
IgG1 anti-Myod
BD-Biosciences Cat. #: 554130
RRID:AB_395255
IF (1:500)
Antibody Mouse monoclonal
IgG1 anti-Pax7
DSHB Cat. #: Pax7
RRID:AB_528428
IF (1:20)
Antibody Mouse monoclonal
IgG2a anti-E-Cad
BD Biosciences Cat. #: 610182
RRID:AB_397581
IF (1:500)
Antibody Mouse monoclonal
IgG1 anti-Myog
DSHB Cat. #: F5D
RRID:AB_2146602
IF (1:20)
Antibody Rabbit polyclonal
anti-SMA
Abcam Cat. #: ab5694
RRID:AB_2223021
IF (1:1000)
Antibody Mouse monoclonal
IgG1 anti-Tnnt3
Sigma Aldrich Cat. #: T6277
RRID:AB_261723
IF (1:200)
Antibody Mouse monoclonal
IgG2a anti-Tuj1
Ozyme/BioLegend Cat. #: BLE801202
RRID:AB_2313773
IF (1:1000)
Antibody Alexa Fluor
633 F(ab’)2
Fragment of Goat
Anti-Rabbit IgG (H+L)
Life Technologies Cat. #: A-21072
RRID:AB_2535733
IF (1:500)
Antibody Alexa Fluor
555 F(ab’)2
Fragment of
Goat Anti-Rabbit IgG (H+L)
Life Technologies Cat. #: A-21430
RRID:AB_2535851
IF (1:500)
Antibody Alexa Fluor
488 F(ab’)2
Fragment of
Goat Anti-Rabbit IgG (H+L)
Life Technologies Cat. #: A-11070
RRID:AB_2534114
IF (1:500)
Antibody Alexa Fluor 633
Goat Anti-Chicken
IgG (H+L)
Life Technologies Cat. #: A-21103
RRID:AB_2535756
IF (1:500)
Antibody Alexa Fluor 488
Goat Anti-Chicken
IgG (H+L)
Life Technologies Cat. #: A-11039
RRID:AB_2534096
IF (1:500)
Continued on next page
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Continued
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Antibody Alexa Fluor 633
Goat Anti-Mouse
IgG1 (g1)
Life Technologies Cat. #: A 21126
RRID:AB_2535768
IF (1:500)
Antibody Alexa Fluor488
AffiniPure Goat
Anti-Mouse IgG1 (g1)
Jackson
ImmunoResearch
Cat. #: 115-545-205
RRID:AB_2338854
IF (1:500)
Antibody Cy3-AffiniPure Goat
Anti-Mouse IgG1 (g1)
Jackson
ImmunoResearch
Cat. #: 115-165-205
RRID:AB_2338694
IF (1:500)
Antibody Cy3-AffiniPure Goat
Anti-Mouse IgG2a (g2a)
Jackson
ImmunoResearch
Cat. #: 115-165-206
RRID:AB_2338695
IF (1:500)
Antibody Dylight 405 Goat
Anti-Mouse IgG2a (g2a)
Jackson
ImmunoResearch
Cat. #: 115-475-206
RRID:AB_2338800
IF (1:500)
Commercial
assay, kit
RNAscope 2.5 HD
reagent Kit-RED
ACD/Bio-techne Cat. #: 322350
Commercial
assay, kit
RNAscope Multiplex Fluorescent
reagent Kit-V2
ACD/Bio-techne Cat. #: 323100
Commercial
assay, kit
RNAscope Probe –
Mm-Hgf (C1)
ACD/Bio-techne Cat. #: 315631
Commercial
assay, kit
RNAscope Probe –
Mm-Met (C1)
ACD/Bio-techne Cat. #: 405301
Commercial
assay, kit
Opal 570
Reagent Pack
PerkinElmer Cat. #: FP1488001KT 1 :1500 of reconstituted
reagent in RNAscope
Multiplex TSA Buffer
Sequence-based
reagent
qPCR Primer
TBP Fw
This paper ATCCCAAGCGATTTGCTG Materials and methods,
Quantitative RT-qPCR section
Sequence-based
reagent
qPCR Primer
TBP Rev
This paper CCTGTGCACACCATTTTTCC Materials and methods,
Quantitative RT-qPCR section
Sequence-
based reagent
qPCR Primer
Isl1 Fw
Gopalakrishnan et al., 2015 CGTGCTTTGTTAGGGATGGGA
Sequence-
based reagent
qPCR Primer Isl1 Rev Gopalakrishnan et al., 2015 AGTCGTTCTTGCTGAAGCCT
Sequence-
based reagent
qPCR Primer Myf5 Fw This paper GACAGGGCTGTTACATTCAGG Materials and methods,
Quantitative RT-qPCR section
Sequence-
based reagent
qPCR Primer Myf5 Rev This paper TGAGGGAACAGGTGGAGAAC Materials and methods,
Quantitative RT-qPCR section
Sequence-
based reagent
qPCR Primer Met Fw Sambasivan et al., 2009 GCATTTTTACGGACCCAACC
Sequence-
based reagent
qPCR Primer Met Rev Sambasivan et al., 2009 TTCACAGCCGGAAGAGTTTC
Sequence-
based reagent
qPCR Primer Hgf Fw This paper CTTCTCCTTGGCCTTGAATG Materials and methods -
Quantitative RT-qPCR section
Sequence-
based reagent
qPCR Primer Hgf Rev This paper AGGCCATGGTGCTACACTCT Materials and methods -
Quantitative RT-qPCR section
Sequence-
based reagent
qPCR Primer SMA Fw This paper CTCTCTTCCAGCCATCTTTCAT Materials and methods -
Quantitative RT-qPCR section
Sequence-
based reagent
qPCR Primer SMA Rev This paper TATAGGTGGTTTCGTGGATGC Materials and methods -
Quantitative RT-qPCR section
Sequence-
based reagent
Taqman qPCR Primers Tbp ThermoFisher Scientific Cat. #: Mm00446971_m1 Sequence not available,
probe spans exons
Sequence-
based reagent
Taqman qPCR Primers Actb ThermoFisher Scientific Cat. #: Mm00607939_s1 Sequence not available,
primers and probe map
within a single exon
Sequence-
based reagent
Taqman qPCR Primers Hprt ThermoFisher Scientific Cat. #: Mm01545399_m1 Sequence not available,
probe spans exons
Continued on next page
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Continued
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Sequence-
based reagent
Taqman qPCR Primers Rpl13a ThermoFisher Scientific Cat. #: Mm01612987_g1 Sequence not available,
probe spans exons
Sequence-
based reagent
Taqman qPCR Primers Rps29 ThermoFisher Scientific Cat. #: Mm02342448_gH Sequence not available,
probe spans exons
Sequence-
based reagent
Taqman qPCR Primers Pax7 ThermoFisher Scientific Cat. #: Mm01354484_m1 Sequence not available,
probe spans exons
Sequence-
based reagent
Taqman qPCR Primers Myod ThermoFisher Scientific Cat. #: Mm01203489_g1 Sequence not available,
probe spans exons
Sequence-
based reagent
Taqman qPCR Primers Myog ThermoFisher Scientific Cat. #: Mm00446195_g1 Sequence not available,
probe spans exons
Sequence-
based reagent
Taqman qPCR Primers Pax3 ThermoFisher Scientific Cat. #: Mm00435491_m1 Sequence not available,
probe spans exons
Sequence-
based reagent
Taqman qPCR Primers Myf5 ThermoFisher Scientific Cat. #: Mm00435125_m1 Sequence not available,
probe spans exons
Sequence-
based reagent
Taqman qPCR Primers Mrf4 ThermoFisher Scientific Cat. #: Mm00435127_g1 Sequence not available,
probe spans exons
Sequence-
based reagent
Taqman qPCR Primers Isl1 ThermoFisher Scientific Cat. #: Mm00517585_m1 Sequence not available,
probe spans exons
Sequence-
based reagent
Taqman qPCR Primers Met ThermoFisher Scientific Cat. #: Mm00436382_m1 Sequence not available,
probe spans exons
Animals
Animals were handled as per European Community guidelines and the ethics committee of the Insti-
tut Pasteur (CTEA) approved protocols. Isl1Cre (Srinivas et al., 2001), reporter mouse lines R26RmT/
mG (Muzumdar et al., 2007), Myf5nLacZ (Tajbakhsh et al., 1996), Tg: Pax7nGFP (Sambasivan et al.,
2009), and mutant mice carrying the Tbx1tm1pa allele (referred to as Tbx1-/-) (Jerome and Papaioan-
nou, 2001), Hgf (Schmidt et al., 1995) and Met (referred as MetD) (Maina et al., 1996) mutant
alleles were described previously. To generate experimental embryos for MetD/D together with Isl1
and Myf5 lineage tracings, MetD/+: Isl1Cre/+: Myf5nlacZ/+ males were crossed with MetD /+: R26RmTmG/
mTmG females. Mice were kept on a mixed genetic background C57BL/6JRj and DBA/2JRj (Janvier
Labs). Mouse embryos and fetuses were collected between embryonic day (E) E12.5 and E18.5, with
noon on the day of the vaginal plug considered as E0.5.
Generation of Isl1-null chimeras
For derivation of Isl1-null ES cells, males and females from Isl1Cre/+ genotype (Srinivas et al., 2001)
were intercrossed to produce heterozygous and homozygous Isl1-null blastocysts. At E3.5, blasto-
cysts were collected from uterine horns and put on culture for 3–6 days in ES derivation medium
composed of GlutaMAX/DMEM (Gibco, 31966), 15% FBS (Biowest), 1% penicillin/streptomycin
(Gibco, 15140, stock 100X), 1% sodium pyruvate (Gibco, 11360, stock 100 mM), 0.1% b-mercaptoe-
thanol (Gibco, 31350–010, stock 50 mM), 1000 U/ml ESGRO recombinant mice leukemia inhibitory
factor (LIF, Millipore, ESG1107, stock 107 U/ml) and 2i (1 mM PD325; Axon Medchem 1408; and 1
mM CH99; Axon Medchem 1386) on gelatin-coated wells with primary Mouse Embryonic Fibroblasts
(MEFs). The disaggregation of ICM was performed with 5 min of 0.05% trypsin-EDTA (GIBCO,
25300–054) treatment and the cell suspension put on culture in ES derivation medium on MEFs.
Derived ES cells were then expanded and genotyped by PCR with specific primers for amplification
of Isl1 WT and mutant sequences (WT primers: ccaagtgcagcataggcttcag; gcagaggccgcgctggatg-
caagg, 230 bp; Mutant primers: tcatgcaagctggtggctgg; gcagaggccgcgctggatgcaagg, 633 bp).
To trace the ES clones, CAG-nlacZ and PGK-puro cassettes were cloned into a pBluescript to pro-
duce a nlacZ reporter puromycin resistant plasmid. Heterozygous and homozygous Isl1-null;nLacZ
ES cells were electroporated (0.5–1  107 cells) with 20 mg of linearized pCAGnlacZ-puro plasmid by
using a BTX Harvard apparatus ECM830 electroporator with one pulse at 240V for 15 ms. Three
days after transfection, positive clones were selected in ES derivation medium with puromycin (1.5
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mg/ml) for 5 days. ES colonies were picked into 24-well plates and tested for expression of the nLacZ
reporter (X-Gal/immunostaining).
For chimera production, the b-gal+ selected clones were further expanded in ES culture medium
(ES derivation medium without 2i) on MEFs. C57BL/6N females were superovulated and mated with
C57BL/6N males. At E3.5, blastocysts were collected, injected with wildtype (control) or homozy-
gous Isl1-null;nlacZ ES cells (2–6 cells/blastocyst) and were subsequently transferred into the uterus
of 0.5 or 2.5 dpc pseudopregnant B6CBAF1 females (15–17 blastocysts/females). Chimeric fetuses
were harvested at E16.5 or E18.5 for analysis. The collected fetuses were dissected in PBS at 4˚C to
remove the caudal part below the stomach, then fixed 3 hr at 4˚C in 4% paraformaldehyde (PFA,
Electron Microscopy Sciences, 15710), 0.5% Triton X-100 (SIGMA, T8787) and extensively washed in
PBS with 0.1% Tween 20 (PBST) (SIGMA, P1379). To evaluate the contribution of ES cells to speci-
mens, X-gal staining was performed on the dissected lower part of the fetuses. The analysis was per-
formed by immunofluorescent stainings on cryosections of the rostral part of the fetuses.
Generation of Tbx1-null chimeras
The Isl1 nuclear lacZ (nlacZ) knock-in mouse 129/SV ES line (Isl1lacZ) was obtained from Sylvia Evans
(Sun et al., 2007). ES cells were cultured on Mytomycin-C treated embryonic primary fibroblasts
onto gelatin coated dishes in DMEM-KO media (Gibco, 10829–018) containing 15% FBS (Biowest),
0,5% penicillin/streptomycin (Gibco, 15140, stock100x), 0.1% b-mercaptoethanol (SIGMA, M7522,
stock 100 mM in PBS), 1% L-Glutamine (Gibco, 25030024, stock 200 mM) and 1000 U/ml ESGRO
recombinant mice leukemia inhibitory factor (LIF, Millipore, ESG1107, stock 107 U/ml).
For ES cell injection and chimera production, 4-week-old Tbx1+/- females were superovulated and
mated with Tbx1+/- males (on a mixed genetic background C57BL/6JRj and DBA/2JRj, Janvier Labs).
At E3.5, blastocysts were collected, injected with Isl1lacZ ES cells (6–12 cells/blastocyst) and were
subsequently transferred into uteri of 0.5 or 2.5 dpc pseudopregnant B6CBAF1 females.
Chimeric fetuses were harvested at E14.5/E15.5 for analysis. The collected fetuses were fixed
2.5 hr at 4˚C in 4% paraformaldehyde 0.2% Triton X-100 and extensively washed in PBS at 4˚C. For
genotyping of the chimeric embryos, the visceral yolk sac layers were separated using the trypsin/
pancreatin method as described in Wallingford and Giachelli (2014) with modifications. Briefly, yolk
sacs were collected and incubated in Ca2+/Mg2+-free Tyrode Ringer’s saline solution containing
0.5% Trypsin (Gibco, 15090–046) and 2.5% Pancreatin (SIGMA, P-3292) for 4 hr at 4˚C on individual
wells of a 12 well plastic dish. Yolk sacs were then washed in GlutaMAX/DMEM (Gibco, 31966021)
media buffered with 25 mM HEPES (SIGMA, H0887) and then transferred into media containing 10%
FBS for at least 30 min at 4˚C. The visceral endoderm (VEnd) and extraembryonic mesoderm (ExM)
tissue layers of the visceral yolk sac were mechanically separated for genotyping. The VEnd layer is
contributed exclusively by the host embryo while the ExM has dual contribution from ES cells and
host embryo. DNA extraction was performed using Proteinase K and PCR performed with the fol-
lowing primers: Tbx1_for: tgcatgccaaatgtttccctg, Tbx1_rs: gatagtctaggctccagtcca, Tbx1_rs_Neo:
agggccagctcattcctcccac (WT band: 196 bp; Mutant band: 450 bp), lacZ_fw: atcctctgcatggtcaggtc,
lacZ_rs: cgtggcctgattcattcccc.
For the analysis of lacZ+ chimeric embryos, the digestive tract including the pharynx, trachea,
esophagus, heart, stomach and diaphragm was further dissected and X-Gal stained overnight at 37˚
C or embryos were processed for cryosections and immunostaining on sucrose/OCT as described
above.
X-Gal staining and immunofluorescence
Wholemount samples were analyzed for b-galactosidase activity with 400 mg/ml X-Gal (SIGMA
15520–018; Stock solution 40 mg/ml in DMSO) in PBS buffer containing 4 mM potassium ferricya-
nide, 4 mM potassium ferrocyanide, 0.02% NP-40 and 2 mM MgCl2 as previously described
(Comai et al., 2014).
For immunostaining on cryosections, embryos and fetuses were fixed 3 hr in 4% PFA and 0,2–
0,5% Triton X-100 at 4˚C, washed overnight at 4˚C in PBS, cryopreserved in 30% sucrose in PBS and
embedded in OCT for cryosectioning. Cryosections (16–18 mm) were allowed to dry for 30 min and
washed in PBS. For immunostaining on paraffin sections, samples were fixed overnight in 4% PFA,
dehydrated in graded ethanol series, Histoclear II (HS-202, National Diagnostics) and embedded in
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paraffin. Paraffin blocks were sectioned at 12 mm using a Leica microtome. Sections were then
deparaffinised and rehydrated by successive immersions in Histoclear, ethanol and PBS series. When
needed, samples were then subjected to antigen retrieval with 10 mM Citrate buffer (pH 6.0) using a
2100 Retriever (Aptum Biologics).
Rehydrated sections were blocked for 1 hr in 10% normal goat serum, 3% BSA, 0.5% Triton X-100
in PBS. Primary antibodies were diluted in blocking solution and incubated overnight at 4˚C. After 3
rounds of 15 min washes in PBST, secondary antibodies were incubated in blocking solution 1 hr at
RT together with 1 mg/ml Hoechst 33342 to visualize nuclei. Antibodies used in the study are listed
in the Key Resource Table. After 3 rounds of 15 min washes in PBST, slides were mounted in 70%
glycerol in PBS for analysis. For EdU staining, immunostaining for primary and secondary antibodies
was performed first, followed by the click chemical reaction using Alexa633 as a reactive fluorophore
for EdU detection (Life Technologies C10350).
For whole mount immunostaining, embryos were fixed and washed as above. Esophagi were
micro-dissected in PBST and incubated in blocking buffer (10% goat serum, 10% BSA, 0.5% TritonX-
100 in 1X PBS) for 1 hr at RT in 2 ml Eppendorff tubes. The tissue was then incubated with primary
antibodies in the blocking buffer for 4–5 days at 4˚C with rocking. The tissue was washed extensively
for 2-4hr in PBST and then incubated in Fab’ secondary antibodies for 2 days at 4˚C with rocking.
The tissue was washed as above, dehydrated in 50% Methanol in PBS, 100% Methanol and then
cleared with BABB and mounted for imaging as in Yokomizo et al. (2012).
RNAscope in situ hybridization
E14.5 embryos were collected, fixed overnight in 4% PFA, washed in PBS 3  15 min, equilibrated in
15% and 30% sucrose and embedded in OCT. Tissue blocks were stored at  80C. 18 mm thick cryo-
sections were collected on Superfrost Plus slides and stored at  80 till use (less than 2 months).
RNAscope probes Mm-Hgf (315631) and Mm-Met (405301) were designed commercially by the
manufacturer and are available from Advanced Cell Diagnostics, Inc. In situ hybridization was per-
formed using the RNAscope Multiplex Fluorescent Reagent Kit V2 and RNAscope 2.5 HD Reagent
Kit-RED according to manufacturer’s instructions (Wang et al., 2012) with some modifications. For
sample pre-treatments: H2O2 treatment was 10 min at RT, retrieval was done for 2 min at 98˚C and
slides were digested with Protease Plus reagent for 15 min at 40˚C. When the RNAscope 2.5 HD
Reagent Kit-RED was used, the AMP1 to AMP6 steps were done as in the standard protocol. Before
detection, samples were washed in PBS 3  5 min and immunostaining performed as above with
fluorescent secondary antibodies. Sections were then washed in RNAscope Wash buffer, detection
done with Fast-Red A/B mix and slides mounted in Fluoromount-G (InterBioTech, FP-483331). As
the Fast-Red chromogenic precipitate is also visible by fluorescence microscopy using the 555 nm
laser, sections were imaged using a 40x objective on a LSM700 microscope (Zeiss). When the RNA-
scope Multiplex Fluorescent V2 kit was used, detection of the probe was done with Opal570 reagent
(Perkin Elmer, FP1488A, 1/1500 in TSA Buffer) prior to immunostaining. For quantitation of Met
RNAscope staining, the number of individual signal dots or clusters per mGFP+ cell was counted
manually on Fiji. Cells were attributed the score 1 (1 to 3 dots/cell), 2 (4 to 9 dots/cell) or 3 (more
than 10 dots/cells or big clusters) and correlated to the presence or absence of Myod/Myog nuclear
staining.
For quantitation of Hgf RNAscope staining per SMA area (Figure 5—figure supplement 1F), a
manual ROI outlining the SMA+ layers was defined in Fiji. Segmentation of the channels was done
using the defaut Auto Threshold for the Hgf/RNAscope channel and the Huang Auto Threshold for
the SMA channel. The measure command was used to calculate the area of the ROI limited to the
threshold for both channels.
Enzymatic digestion for cell sorting
The masseter muscles and esophagi from Tg:Pax7-nGFP timed embryos were dissected in cold PBS
and kept in cold GlutaMAX/DMEM (Gibco, 31966) with 1% Penicillin–Streptomycin. For single cell
qPCR analysis, only mGFP+ cells from the mononucleated cell front (mcf) of the esophagus of Isl1-
Cre:R26mTmG embryos were micro-dissected under a Zeiss SteREO Discovery V20 macroscope. Sam-
ples were processed with enzymatic digestion mix containing 0.1% Trypsin (15090–046,Gibco),
0,08% Collagenase D (Roche, 11088882001) and 10 mg/ml of DNAse I (04536282001, Roche) in
Comai et al. eLife 2019;8:e47460. DOI: https://doi.org/10.7554/eLife.47460 20 of 27
Research article Developmental Biology Evolutionary Biology
DMEM/Glutamax. Samples were incubated for 15 min at 37˚C under 300 rpm agitation and resus-
pended by gently pipetting up and down 10–15 times using a P1000 pipette. Incubation and resus-
pension by pipetting were repeated for two additional 15 min enzymatic treatments. The digests
were passed through a 70 micron then 40 micron SmartCell Strainers (Milteny Biotec) and digestion
was stopped with fetal bovine serum (FBS, Gibco). Cells were spun at 600 g 15 min at 4˚C and the
pellets resuspended in 300 ml of DMEM/2% FBS to be processed for FACS.
Quantitative RT-qPCR
Total RNA from esophagus portions and limbs was extracted through manual pestle tissue disrup-
tion in TRIzol, followed by DnaseI treatment and purification with the Qiagen RNAeasy Mini purifica-
tion Kit. Pax7-nGFP+ cells were isolated by FACS directly into cell lysis buffer (RLT) of the Qiagen
RNAeasy Plus Micro purification Kit and total RNA extracted according to the kit instructions. cDNA
was prepared from 0,4 mg up to 5 mg of total RNA by random-primed reverse transcription (Super-
Script III, ThermoFisher 18010093) and real-time PCR was done using SYBR Green Universal Mix
(Roche, 13608700) and StepOne-Plus Real Time PCR System (Applied Biosystems). TBP transcript
levels were used for normalizations of each target (2DCT). At least three biological replicates and
technical duplicates were used for each condition method (Schmittgen et al., 2008). For SYBR-
Green, custom primers were designed using the Primer3Plus online software. Serial dilutions of total
cDNA were used to calculate the amplification efficiency of each primer set according to the equa-
tion: E = 10–1/slope. Primer sequences used are detailed in the Key Resource Table.
Single-cell qPCR analysis
Gene expression in single cells was analyzed using the Fluidigm Gene Expression Assay (BioMark).
Briefly, oesophagus was dissected and digested with trypsin/collagenase to obtain a single cell sus-
pension as described above. Single cells and bulk control (20 cells/well) were sorted directly on a
FACS Aria III in 9 ml of Specific Target Amplification (STA) reaction mix from the CellsDirect One-
Step qRT-PCR kit (Invitrogen) containing 0.2XTaqMan Gene Expression Assay mix. Pre-amplified
cDNA (18 cycles) was obtained according to manufacturer’s note and was diluted 1:5 in TE buffer
for qPCR. Multiplex qPCR was performed using the microfluidics Biomark system on a Biomark HD
for 40 cycles. The same TaqMan probes were used for both RT/STA and qPCR. TaqMan assays used
in the study are listed in the Key Resource Table.
Conversion to relative expression
Raw Ct values were converted in relative expression using the following formula: Log2ex = LOD – Ct
[Array] (Livak et al., 2013). With the LOD standing for the Limit Of Detection. When the Log2ex
value obtained was negative (Ct[array]>LOD) the value was replaced by 0. To set up the LOD, we
round the mean of the maximum Ct values for all the genes to the upper limit which gives a LOD of
21.
Normalization
The resulting relative expression values were normalized to the endogenous controls by subtracting,
for each cell, the average of its Actb, Rpl13, Rps29, and Hprt expression levels.
An offset corresponding to the mean of all the calculated means was applied to all obtained val-
ues to avoid negative values.
Single cell filtering
From two independent experiments 66 cells were collected from the esophagus. The criteria to
keep a cell for further analysis were the following: i) to discard neurogenic progenitors, cells should
not express Pax3 and/or Lhx3. ii) at least 4 out of the five positive control genes should be
expressed, as well as at least 2 of the genes of interest. Applying this different filters 23 single cells
were selected.
Correlation coefficient determination and p-value calculation
The Spearman’s rho correlation coefficient was calculated using the R function cor() with the ‘use’
parameter set at « pairwise.complete.obs », and all the null values previously replaced by
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NAs. The coefficient correlation p-value was extracted from the cor.test() R function, using the
same parameters.
Data visualization
The heatmap (Figure 5—figure supplement 2B) was generated using the pheatmap R package
(pheatmap_1.0.10) with default parameters, and the correlogram (Figure 5F) was generated using
the corrplot R package (corrplot_0.84), with the p-values manually added. Violin plots (Figure 1—
figure supplement 1H,J) were made in R using the ggplot2 package (ggplot2_3.1.0). R session info:
R version 3.5.1 (2018-07-02), platform: x86_64-apple-darwin15.6.0 (64-bit), running under: macOS
Sierra 10.12.6.
Static imaging
Images were acquired using the following systems: Zeiss SteREO Discovery V20 microscope for
whole embryos, a Zeiss Axioplan equipped with an Apotome and ZEN software (Carl Zeiss) or
a Leica TCS-SP8 with Leica Application Suite (LAS) software for tissue sections and a LSM 700 laser-
scanning confocal microscope and ZEN software (Carl Zeiss) for tissue sections and whole mount
immunostaining of cleared embryos. All images were assembled in Adobe Photoshop and InDesign
(Adobe Systems). Volume-3D rendering of the z-stack series was performed in Imaris (version 7.2.1)
software (Bitplane).
Explant culture
Esophagi from E14.5 Isl1Cre/+:R26mTmG/+ embryos were micro-dissected leaving the stomach and
pharyngeal muscles attached in RT HBSS (Gibco, 14025). The esophagi were immobilized on individ-
ual wells of 8 well glass bottom dishes (Ibidi, 80826) at the stomach and pharyngeal ends using 0.3
ml of Vetbond tissue adhesive (3M, 1469 SB). The explants were immediately embedded in a colla-
gen matrix as previously reported (Placzek and Dale, 1999) with slight modifications. 700 ml of colla-
gen-I (Corning, 354236), 200 ml of reconstituted 5X DMEM-F12 (SIGMA, D2906) and 100 ml
neutralization buffer (50 mM NaOH, 260 mM NaHCO3, 200 mM Hepes) were mixed and kept on
ice. 200 ml of collagen matrix was added to each explant and allowed to polymerize for 10 min in a
culture incubator at 37˚C, 5% CO2. Explant culture medium was composed of Opti-MEM (Gibco,
51985–026) with 1% P/S and 20% FCS. 250 ml of culture medium containing Met inhibitors or the
equivalent amount of DMSO (control) was added to each well and allowed to equilibrate for 30 min
in a culture incubator. The Met inhibitors used were MGCD-265 (10 mM, Selleck, 50 mM stock in
DMSO) and PF-0417903 (10–20 mM, AbMole, 26.8 mM stock in DMSO).
For static cultures, images of individual wells were acquired at 6 to 12 hr intervals on a Zeiss Ste-
REO Discovery V20 macroscope as Z-stacks and processed with the extended depth focus function
on the ZEN software (Carl Zeiss).
For time-lapse imaging, the dish was placed in a microscope incubator chamber (37˚C, 5% CO2)
and the mGFP signal imaged with the 488 laser on an Leica TCS-SP8 inverted microscope, equipped
with a HC PL APO CS2 10X/0.40 dry objective and HyD hybrid detector (496–566 nm). Confocal
imaging of optical Z-planes (2.41 mm) were acquired every 15 min over 14 hr using LAS X software.
Z-stacks were projected as maximum intensity projection images, stitched and registered (linear reg-
istration) in Fiji. The migrating cells were tracked individually frame-by-frame using the ‘Manual
Tracking’ plugin in Fiji. The following parameters were quantitated: total distance (mm, the distance
covered by the whole track), velocity (mm/min, ratio between the total distance and total time of the
track), displacement (mm, the length of the resultant vector between ti and tf of the track), efficiency
(ratio between displacement and total distance), net velocity (mm/min, ratio between the displace-
ment and total time of the track).
Quantitation of muscle area
The muscle area on transverse esophagus cryosections (Figure 1—figure supplement 1I) was quan-
tified on Fiji. Channels were split and threshold levels adjusted on the Tnnt3 channel. The freehand
selection tool was used to trace the outline of each esophagus cross section (referred as Region of
interest, ROI). Threshold levels were kept constant for all samples. The Analyze/Measure tool was
set to calculate the area of the ROI limited to the threshold for the Tnnt3 channel.
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EdU Administration In Vivo
For proliferation experiments in vivo, 5-ethyl-20-deoxyuridine (EdU; Invitrogen E10187) was injected
intraperitoneally and detected as described in Comai et al. (2014).
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